DNA Labs International

DNA Labs International

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

DNA Labs International is a leading provider of forensic DNA testing services, operating since 2004 with accreditations from ANAB (ISO/IEC 17025:2017) and the FBI Quality Assurance Standards. The company serves a global client base of law enforcement and legal professionals, offering end-to-end solutions for a wide range of evidence types, supported by its proprietary technology suite including the DNA Toolbox™, Helix HITS™, and Rosalind AI™. As a private, founder-led organization, DLI emphasizes a victim-centric, partnership-driven culture, leveraging cutting-edge forensic genomics and genealogical research to solve crimes and support post-conviction relief. Its business model is purely service-based within the diagnostics and forensic services sector.

DiagnosticsGenetics & Genomics

Technology Platform

Proprietary 'DNA Toolbox™' suite including Helix HITS™ for high-sensitivity processing, Secure SNP™ for forensic SNP analysis, Rosalind AI™ for complex mixture interpretation, and tools for CODIS integration and local DNA database management.

Opportunities

Significant growth is driven by government funding to clear forensic backlogs (e.g., sexual assault kits), the expanding application of investigative genetic genealogy to solve cold cases, and the ongoing need for private lab capacity as public labs remain overburdened.
International expansion presents a further opportunity.

Risk Factors

Key risks include dependency on government grants and agency budgets, the potential for regulatory changes restricting genetic genealogy practices, and the constant need to maintain critical FBI and ISO accreditations.
Reputational damage from a high-profile error is an ever-present concern.

Competitive Landscape

DLI competes with other large private forensic DNA labs like Bode Technology and ANDE, as well as public crime laboratories. Competition is based on technological capability (especially for degraded DNA and genetic genealogy), turnaround time, cost, accreditation, and the quality of expert support and testimony.